Cargando…
Adalimumab for treatment of very early onset inflammatory bowel disease
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940072/ https://www.ncbi.nlm.nih.gov/pubmed/31856064 http://dx.doi.org/10.1097/CM9.0000000000000528 |
| _version_ | 1783484288456458240 |
|---|---|
| author | Xie, Yao Liu, Li-Li Jiang, Yi Tang, Ze-Zhong Sun, Guo-Yu Hou, Xin-Lin |
| author_facet | Xie, Yao Liu, Li-Li Jiang, Yi Tang, Ze-Zhong Sun, Guo-Yu Hou, Xin-Lin |
| author_sort | Xie, Yao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6940072 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69400722020-02-04 Adalimumab for treatment of very early onset inflammatory bowel disease Xie, Yao Liu, Li-Li Jiang, Yi Tang, Ze-Zhong Sun, Guo-Yu Hou, Xin-Lin Chin Med J (Engl) Correspondence Wolters Kluwer Health 2019-12-05 2019-12-05 /pmc/articles/PMC6940072/ /pubmed/31856064 http://dx.doi.org/10.1097/CM9.0000000000000528 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
| spellingShingle | Correspondence Xie, Yao Liu, Li-Li Jiang, Yi Tang, Ze-Zhong Sun, Guo-Yu Hou, Xin-Lin Adalimumab for treatment of very early onset inflammatory bowel disease |
| title | Adalimumab for treatment of very early onset inflammatory bowel disease |
| title_full | Adalimumab for treatment of very early onset inflammatory bowel disease |
| title_fullStr | Adalimumab for treatment of very early onset inflammatory bowel disease |
| title_full_unstemmed | Adalimumab for treatment of very early onset inflammatory bowel disease |
| title_short | Adalimumab for treatment of very early onset inflammatory bowel disease |
| title_sort | adalimumab for treatment of very early onset inflammatory bowel disease |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940072/ https://www.ncbi.nlm.nih.gov/pubmed/31856064 http://dx.doi.org/10.1097/CM9.0000000000000528 |
| work_keys_str_mv | AT xieyao adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease AT liulili adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease AT jiangyi adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease AT tangzezhong adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease AT sunguoyu adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease AT houxinlin adalimumabfortreatmentofveryearlyonsetinflammatoryboweldisease |